Malta - English - Medicines Authority

laboratoires omega pharma france 2 rue chaintron, bp 850, 92542 montrouge, france - piperonyl butoxide, depallethrine - cutaneous liquid - piperonyl butoxide 4.4 % (w/w) depallethrine 1.1 % (w/w) - ectoparasiticides, incl. scabicides, insecticides and repellents

Malta - English - Medicines Authority

laboratoires omega pharma france 2 rue chaintron, bp 850, 92542 montrouge, france - piperonyl butoxide, depallethrine - cutaneous spray, solution - piperonyl butoxide 7.2 % (w/w) depallethrine 1.8 % (w/w) - ectoparasiticides, incl. scabicides, insecticides and repellents

Malta - English - Medicines Authority

laboratoires omega pharma france 2 rue chaintron, bp 850, 92542 montrouge, france - permethrin, piperonyl butoxide, malathion - cutaneous spray, solution - permethrin 1 % (w/w) piperonyl butoxide 4 % (w/w) malathion 0.5 % (w/w) - ectoparasiticides, incl. scabicides, insecticides and repellents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

omega pharma ltd - halogenated phenols; phenol - cutaneous or oromucosal liquid - 6.8mg/1ml ; 1.75mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoires juvise pharmaceuticals - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

laboratoires besins international, france - testosterone - gel - 16.2 mg/g,

Israel - English - Ministry of Health

medison pharma ltd - ivabradine as hydrochloride - film coated tablets - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Israel - English - Ministry of Health

medison pharma ltd - ivabradine as hydrochloride - film coated tablets - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

laboratoires juvisé pharmaceuticals, france - hydrochlorothiazide - tablet - 25 mg

European Union - English - EMA (European Medicines Agency)

laboratoires smb s.a. - fenofibrate, pravastatin - dyslipidemias - lipid modifying agents - pravafenix is indicated for the treatment of high-coronary-heart-disease (chd)-risk adult patients with mixed dyslipidaemia characterised by high triglycerides and low hdl-cholesterol (c) levels whose ldl-c levels are adequately controlled while on a treatment with pravastatin-40-mg monotherapy.